Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020Investors Business Daily • 12/13/19
Celgene Gave This Tech Back to Editas Medicine, but It Could Prove ValuableThe Motley Fool • 12/05/19
Bristol-Myers Has Now Acquired Celgene — So, Should You Buy BMY Stock?Investors Business Daily • 12/04/19
Why I'm Holding On to My Bristol-Myers Squibb Shares Now That the Celgene Acquisition Has ClosedThe Motley Fool • 11/24/19
FTC makes Celgene's Otezla divestiture official condition for Bristol-Myers acquisitionMarket Watch • 11/15/19
Bristol-Celgene Merger Leaps FTC Clearance; Deal Set To Close WednesdayInvestors Business Daily • 11/15/19
Bristol-Myers Squibb wins antitrust approval to buy Celgene on condition it sell psoriasis drugReuters • 11/15/19
Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even BetterThe Motley Fool • 11/12/19